Please check your internet connection and try again.
# Genixim (Cefixime)
## Overview
Genixim is a third-generation cephalosporin antibiotic. It provides broad-spectrum coverage against Gram-negative bacteria (e.g., *Haemophilus influenzae*, *Moraxella catarrhalis*, *Neisseria gonorrhoeae*) and limited Gram-positive coverage. It is administered orally and exhibits time-dependent bactericidal activity.
## Primary Indications
* Uncomplicated urinary tract infections (UTIs)
* Otitis media
* Pharyngitis and tonsillitis
* Gonococcal infections (uncomplicated cervical, urethral, and rectal)
* Acute bronchitis and acute exacerbations of chronic bronchitis
## Adult Dosing
* **General infections:** 400 mg daily, administered as a single dose or in two divided doses (200 mg every 12 hours).
* **Uncomplicated Gonorrhea:** 800 mg as a single oral dose.
* **Maximum dose:** 400 mg once daily is standard; higher doses are reserved for specific protocols (e.g., CDC guidelines for gonorrhea).
## Pediatric Dosing
* **General infections (≥6 months old):** 8 mg/kg/day, administered as a single dose or in two divided doses (4 mg/kg every 12 hours).
* **Otitis media:** 8 mg/kg daily as a single dose or in two divided doses.
* **Maximum pediatric dose:** 400 mg/day.
## Dose Adjustments
* **Renal Impairment:** If CrCl is 21–60 mL/min, administer 75% of the standard dose. If CrCl <20 mL/min, administer 50% of the standard dose.
* **Hepatic Impairment:** No specific adjustment required.
## Contraindications
* Known hypersensitivity to cefixime or other cephalosporins.
* History of severe allergic reactions (e.g., anaphylaxis) to penicillins or other beta-lactams (cross-reactivity risk).
## Adverse Effects
* **Common:** Diarrhea (often dose-related), abdominal pain, nausea, dyspepsia, and headache.
* **Serious:** *Clostridioides difficile*-associated diarrhea, hypersensitivity reactions (rash, urticaria, serum sickness), and rare cases of Stevens-Johnson syndrome or toxic epidermal necrolysis.
## Key Drug Interactions
* **Anticoagulants:** May enhance the effects of warfarin (monitor INR).
* **Probenecid:** Increases serum concentrations of cefixime by reducing renal tubular secretion.
* **Vaccines:** Avoid co-administration with oral typhoid vaccine (antibiotic may reduce vaccine efficacy).
## Monitoring
* Monitor for signs of hypersensitivity.
* Monitor bowel frequency if persistent diarrhea occurs.
* For prolonged therapy: Periodic assessment of renal and hepatic function.
## Clinical Pearls
* **Bioavailability:** Suspension form may provide higher peak concentrations compared to tablets.
* **Administration:** May be taken with or without food.
* **Spectrum Gap:** Cefixime has poor activity against *Staphylococcus aureus* and *Pseudomonas aeruginosa*. It should not be used as monotherapy for infections where these pathogens are suspected.
* **Storage:** Once reconstituted, the oral suspension typically requires storage at room temperature and usually expires after 14 days (verify specific manufacturer labeling).
***
**Educational Disclaimer:** This information is for educational purposes only. Always consult the latest package insert, official clinical guidelines (such as CDC or local antimicrobial stewardship protocols), and institutional pharmacy policies before prescribing or administering medication. Dosage must be verified against patient-specific factors.
